A population-based analysis of second primary cancers after irradiation for rectal cancer

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 30, Issue 4, 2007, Pages 333-339

  Kendal, Wayne S ^a,b   Nicholas, Garth ^a,b  

^a OTTAWA REGIONAL CANCER CENTRE   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Prostatic carcinoma; Radiotherapy; Rectal cancer; SEER

Indexed keywords

ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER REGISTRY; CLINICAL DECISION MAKING; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; METASTASIS; PROPORTIONAL HAZARDS MODEL; RECTUM CANCER;

AGED; CANADA; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; PELVIS; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; SEER PROGRAM;

EID: 34548456414     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/01.coc.0000258084.55036.9e     Document Type: Article

References (36)

1. Havenga K, Enker WE, Norstein J, et al. Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: an international analysis of 1411 patients. Eur J Surg Oncol. 1999;25:368-374.
2. NIH-Consensus-Conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA. 1990;264:1444-1450.
3. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345:638-646.
4. Sauer R. Adjuvant versus neoadjuvant combined modality treatment for locally advanced rectal cancer: first results of the German rectal cancer study (CAO/ARO/AIO-94). Int J Radiat Oncol Biol Phys. 2003; 57(suppl 2):124-125.
5. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med. 1997;336:980-987.
6. O'Neil BH. Systemic therapy for colorectal cancer: focus on newer chemotherapy and novel agents. Semin Radiat Oncol. 2003;13:441-453.
7. Baxter NN, Tepper JE, Durham SB, et al. Increased risk of rectal cancer after prostate radiation: a population-based study. Gastroenterology. 2005;128:819-824.
8. Reinberg S. Radiation for Prostate Cancer May Make Rectal Cancer More Likely. Washington, DC: Healthfinder: National Health Information Center, U.S. Department of Health & Human Services, 2005.
9. Kirkey S. Radiation for prostate cancer doubles rectal cancer risk. National Post. April 1, 2005.
10. Kendal WS, Eapen L, MacRae R, et al. Prostatic irradiation is not associated with any measurable increase in the risk of subsequent rectal cancer. Int J Radiat Oncol Biol Phys. 2006;65:661-668.
11. Upton AC. The dose-response relation in radiation-induced cancer. Cancer Res. 1961;21:717-729.
12. Cuzick J. Radiation-induced myelomatosis. N Engl J Med. 1981;304: 204-210.
13. Kleinerman RA, Curtis RE, Boice JD Jr, et al. Second cancers following radiotherapy for cervical cancer. J Natl Cancer Inst. 1982;69:1027-1033.
14. Boice JD Jr, Day NE, Andersen A, et al. Second cancers following radiation treatment for cervical cancer: an international collaboration among cancer registries. J Natl Cancer Inst. 1985;74:955-975.
15. Pettersson F, Fotiou S, Einhorn N, et al. Cohort study of the long-term effect of irradiation for carcinoma of the uterine cervix: second primary malignancies in the pelvic organs in women irradiated for cervical carcinoma at Radiumhemmet 1914-1965. Acta Radiol Oncol. 1985;24:145-151.
16. Boice JD, Blettner M, Kleinerman RA, et al. Radiation dose and leukemia risk in patients treated for cancer of the cervix. J Natl Cancer Inst. 1987;79:1295-1311.
17. Jao SW, Beart RW Jr, Reiman HM, et al. Colon and anorectal cancer after pelvic irradiation. Dis Colon Rectum. 1987;30:953-958.
18. Arai T, Nakano T, Fukuhisa K, et al. Second cancer after radiation therapy for cancer of the uterine cervix. Cancer. 1991;67:398-405.
19. Hall PF. Cancer risks after medical radiation. Med Oncol Tumor Pharmacother. 1991;8:141-145.
20. Boice J, Harvey E, Blettner M, et al. Cancer in the contralateral breast after radiotherapy for breast cancer. N Engl J Med. 1992;326:781-785.
21. Boice JD Jr. Cancer following irradiation in childhood and adolescence. Med Pediatr Oncol Suppl. 1996;1:29-34.
22. Movsas B, Hanlon AL, Pinover W, et al. Is there an increased risk of second primaries following prostate irradiation? Int J Radiat Oncol Biol Phys. 1998;41:251-255.
23. Hall EJ, Wuu C-S. Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys. 2003;56:83-88.
24. Neugut AI, Ahsan H, Robinson E, et al. Bladder carcinoma and other second malignancies after radiotherapy for prostate carcinoma. Cancer. 1997;79:1600-1604.
25. Brenner DJ, Curtis RE, Hall EJ, et al. Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery. Cancer. 2000;88:398-406.
26. Birgisson H, Pahlman L, Gunnarsson U, et al. Occurrence of second cancers in patients treated with radiotherapy for rectal cancer. J Clin Oncol. 2005;23:6126-6131.
27. Fritz A, Ries L. The SEER Program Code Manual, 3rd ed. Bethesda, MD: Cancer Statistics Branch, Surveillance Program, Division of Cancer Control and Population Sciences, National Cancer Institute, 1998.
28. Travis LB, Fossa SD, Schonfeld SJ, et al. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst. 2005;97:1354-1365.
29. Zar JH. Biostatistical Analysis, 2nd ed. Englewood Cliffs, NJ: Prentice-Hall, 1984.
30. Satagopan JM, Ben-Porat L, Berwick M, et al. A note on competing risks in survival data analysis. Br J Cancer. 2004;91:1229-1235.
31. Karpeh M, Kelsen DP, Tepper JE. Cancer of the stomach. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer Principles & Practice of Oncology, 6th ed. Philadelphia: Lippincott Williams & Wilkins, 2001: 1092-1126.
32. Carroll PR, Lee KL, Fuks ZY Cancer of the prostate. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer Principles & Practice of Oncology, 6th ed. Philadelphia: Lippincott Williams & Williams, 2001: 1418-1479.
33. McKean-Cowdin R, Feigelson HS, Ross RK, et al. Declining cancer rates in the 1990s. J Clin Oncol. 2000;18:2258-2268.
34. Wirk B. The role of ovarian ablation in the management of breast cancer. Breast J. 2005;11:416-424.
35. Storm HH. Second primary cancer after treatment for cervical cancer: late effects after radiotherapy. Cancer. 1988;61:679-688.
36. Friberg S, Mattson S. On the growth rates of human malignant tumors: implications for medical decision making. J Surg Oncol. 1997;65: 284-297.